Sign in

CIK 0001789972 · Non-accelerated filer<br>Smaller reporting company

Cullinan Therapeutics, Inc.

Sign in to watch
Ticker
CGEM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
813879991
Phone
617-410-4650
Business address
ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
Former names
Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
  1. 8-K Event Regulation FD disclosure · Other events
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations · Executive or director change
  9. SCHEDULE 13G Stake Statement of Beneficial Ownership
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 8-K Event Shareholder vote results
  16. 8-K Event Material agreement · Regulation FD disclosure
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations
  19. ARS Other Annual Report to Security Holders
  20. DEFA14A Proxy Proxy Materials

Page 6 of 24 · 471 filings